Sol Medic Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 25-07-2024
- Paid Up Capital ₹ 4.00 Cr
as on 25-07-2024
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.10 Cr
as on 25-07-2024
- Satisfied Charges ₹ 9.00 Cr
as on 25-07-2024
- Revenue %
(FY 2023)
- Profit 78.50%
(FY 2023)
- Ebitda 91.02%
(FY 2023)
- Net Worth -1.91%
(FY 2023)
- Total Assets -13.65%
(FY 2023)
About Sol Medic
The Corporate was formerly known as Sol Laboratories Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 4.00 Cr.
The company currently has active open charges totaling ₹6.10 Cr. The company has closed loans amounting to ₹9.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Tarun Kumar, Omesh Sethi, and Vijayata Sethi serve as directors at the Company.
- CIN/LLPIN
U17210WB2011PLC218319
- Company No.
218319
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 May 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sol Medic Limited offer?
Sol Medic Limited offers a wide range of products and services, including Spacers and Standoffs, Self Clinching Standoff, Ayurvedic Digestive Medicine, Anti Constipation Powder, IVDs & Analyzers, Electrolyte Analyzer, Multivitamin Syrup & Drops, Multivitamin Drops, Pharmaceutical Syrup, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at Sol Medic?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tarun Kumar  | Director | 23-Apr-2013 | Current |
| Omesh Sethi | Director | 10-May-2011 | Current |
| Vijayata Sethi | Director | 07-Jul-2011 | Current |
Financial Performance and Corporate Structure Insights of Sol Medic.
Sol Medic Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 78.5% increase in profit. The company's net worth dipped by a decrease of 1.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sol Medic?
In 2023, Sol Medic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Stanvie Industries Private LimitedActive 4 months 1 day
Omesh Sethi and Vijayata Sethi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Religare Finvest Limited Creation Date: 26 Feb 2016 | ₹6.10 Cr | Open |
Bank Of India Creation Date: 24 Nov 2015 | ₹1.00 Cr | Satisfied |
Bank Of India Creation Date: 11 Feb 2012 | ₹8.00 Cr | Satisfied |
How Many Employees Work at Sol Medic?
Sol Medic has a workforce of 37 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sol Medic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sol Medic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
